Advertisement
Advertisement

VIVS

VIVS logo

VivoSim Labs, Inc. Common Stock

1.39
USD
Sponsored
-0.02
-1.42%
May 08, 16:00 UTC -4
Closed
exchange

After-Market

1.43

+0.04
+2.52%

VivoSim Labs, Inc. Common Stock Profile

About

VivoSim Labs Inc. is a clinical-stage biotechnology company. It involved in developing drugs which are demonstrated to be effective in three-dimensional human tissues as candidates for drug development. The company focuses on developing novel treatment approaches in inflammatory bowel disease. VivoSim Labs Inc., formerly known as Organovo Holdings Inc., is based in SAN DIEGO, United States.

Info & Links

CEO

Keith Murphy

Headquarters

11555 SORRENTO VALLEY ROAD, SUITE 100
SAN DIEGO, CA 92121, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.vivosim.ai

Auditor

Rosenberg Rich Baker Berman, P.A.

Share holders

64

Employees

13

VivoSim Labs, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

4.12M

Enterprise Value

-163.31K

Enterprise Value/EBITDA(ttm)

0.01

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

28.10

Price to Book(mrq)

0.90

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-861.27%

Profit Margin(ttm)

-3421.94%

Return on Equity(ttm)

-15.51%

Return on Invested Capital(ttm)

-61.08%

Return on Assets(ttm)

-11.31%

Income Statement

Revenue(ttm)

142.00K

Revenue Per Share(ttm)

0.05

Gross Profit(ttm)

142.00K

EBITDA(ttm)3

-11.22M

Net Income Available to Common(ttm)

-1.23M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

1.43

52-Week Change

-29.80%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

2.61M

Dividend Yield

0.00%

Float4

2.54M

% Held by Insiders

2.50%

% Held by Institutions

8.23%

Balance Sheet

Total Cash(mrq)

4.29M

Total Cash Per Share(mrq)

1.64

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

2.44%

Quick Ratio(mrq)

2.44%

Book Value Per Share(mrq)

1.70

Cash Flow

Operating Cash Flow Per Share(ytd)

-3.29

Free Cash Flow(ytd)

-8.59M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement